Bar graphs represent the averages ± SEM from three biological replicates for total RNA profiling, and for three technical replicates for Ago2-IP.
Western blot analysis showed no changes in the subcellular localisation of HuR upon miR-17-19b overexpression. Vcl and H2A.X were used as markers for cytoplasmic and nuclear extracts, respectively. (c) Cytoplasmic extracts from control and miR-17-19b overexpressing cells were subjected to IPs using anti-HuR, followed by anti-PhosphoSerine/Threonine (pS/T) western blot analysis. Two experimental replicas are shown. (d) Cytoplasmic extracts from control and miR cells were subjected to IP using anti-pS/T antibody, followed by anti-HuR western blot analysis. (e) HuR-IPs -treated and untreated with -protein phosphatase-were subjected to western blot analysis using anti-HuR and anti-pS/T antibodies. 
